Inflammatory mediators in eyelid vasculature

"Inflammatory mediators in eyelid vasculature" is not the name of a specific molecule, receptor, or canonical drug target. Instead, it refers broadly to various signaling molecules (such as cytokines, chemokines, histamine, platelet-activating factor) that are released during inflammatory processes affecting the blood vessels of the eyelid. These mediators play roles in immune cell recruitment and vascular permeability during conditions like hordeolum (stye), chalazion, cellulitis, and allergic or autoimmune reactions[1][4][5]. Because this term does not specify a single molecular entity but rather describes a group of factors involved in inflammation within eyelid blood vessels, it cannot be mapped to structured information for an individual therapeutic target.